Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bergner

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Epilepsia|December 11, 2021
Genetic testing for the epilepsies: A systematic reviewBeth R Sheidley, Jennifer Malinowski, Amanda L Bergner, et al.
Plos One|March 9, 2013
Validation of eDNA surveillance sensitivity for detection of Asian carps in controlled and field experimentsAndrew R Mahon, Christopher L Jerde, Matthew Galaska, et al.
Plos One|March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine modelSteven D Rhodes, Wei Zhang, Dalong Yang, et al.
Epilepsia|June 24, 2023
Knowledge and beliefs about epilepsy genetics among Hispanic and non-Hispanic patientsShannon Trujillo, John B Wetmore, Itzel A Camarillo, et al.
Pediatrics|July 4, 2006
Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylationRonald D Cohn, Erik Eklund, Amanda L Bergner, et al.
Neurology|August 17, 2016
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular SchwannomasJaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular SchwannomasJaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Behavioural Brain Research|June 23, 2009
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafishRupert J Egan, Carisa L Bergner, Peter C Hart, et al.
American Journal of Medical Genetics. Part A|October 21, 2016
Creation of an international registry to support discovery in schwannomatosisK L Ostrow, A L Bergner, J Blakeley, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Epilepsia|December 11, 2021
Genetic testing for the epilepsies: A systematic reviewBeth R Sheidley, Jennifer Malinowski, Amanda L Bergner, et al.
Plos One|March 9, 2013
Validation of eDNA surveillance sensitivity for detection of Asian carps in controlled and field experimentsAndrew R Mahon, Christopher L Jerde, Matthew Galaska, et al.
Plos One|March 19, 2015
Dystrophic spinal deformities in a neurofibromatosis type 1 murine modelSteven D Rhodes, Wei Zhang, Dalong Yang, et al.
Epilepsia|June 24, 2023
Knowledge and beliefs about epilepsy genetics among Hispanic and non-Hispanic patientsShannon Trujillo, John B Wetmore, Itzel A Camarillo, et al.
Pediatrics|July 4, 2006
Intracranial hemorrhage as the initial manifestation of a congenital disorder of glycosylationRonald D Cohn, Erik Eklund, Amanda L Bergner, et al.
Neurology|August 17, 2016
Patient-reported outcomes of pain and physical functioning in neurofibromatosis clinical trialsPamela L Wolters, Staci Martin, Vanessa L Merker, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular SchwannomasJaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2026
Erratum: Efficacy and Biomarker Study of Bevacizumab for Hearing Loss Resulting From Neurofibromatosis Type 2-Associated Vestibular SchwannomasJaishri O Blakeley, Xiaobu Ye, Dan G Duda, et al.
Behavioural Brain Research|June 23, 2009
Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafishRupert J Egan, Carisa L Bergner, Peter C Hart, et al.
American Journal of Medical Genetics. Part A|October 21, 2016
Creation of an international registry to support discovery in schwannomatosisK L Ostrow, A L Bergner, J Blakeley, et al.
Pageof 10